Aurora Cannabis (TSX:ACB) Stock Releases Earnings Bomb!

Aurora (TSX:ACB)(NYSE:ACB) stock saw some big moves after the company announced earnings on top of a stellar week of share movement.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aurora Cannabis (TSX:ACB)(NYSE:ACB) finally had some good news for investors on Nov. 9, after Aurora stock announced its earnings on Tuesday after the market closed. This came after the company saw more activity in its shares than it has in months.

What happened?

Aurora stock reported a significant comeback in earnings, demolishing estimates by analysts. True, the company still reported a loss of $11.9 million. However, this is far from the $101.4 million loss the same quarter last year.

But the real growth can be seen in Aurora stock’s earnings per share (EPS). At the same time last year, the company announced a loss of $0.85 EPS. This quarter, estimates came in at an average loss of $0.21 EPS. Instead, Aurora stock announced an EPS loss of just $0.06, beating analyst estimates for the first time in the last several quarters.

Management claims it’s all about focus. Aurora stock now focuses on its premium products as recreational use grows. Aurora has always been known as the company producing pot at the cheapest price. It seems that’s about to change. And it already has. In fact, its average net selling price per gram of dried cannabis increased to $4.67 per gram from $3.86 the same quarter last year, though this is still shy of the $5.11 in the last quarter.

Aurora stock now claims revenue of $60.1 million from the quarter, down from $67.6 million the year before. However, as it streamlines its business, identifying cash savings between $60 and $80 million, management believes it’s finally running full steam ahead.

So what?

This news comes on top of the share growth experienced by Aurora stock after an announcement by management on Nov. 8. The company announced it would acquire Growery for an undisclosed price. It’s hoped that this new investment would see more recreational sales, as Aurora continues to lag behind in this area.

What’s more, Aurora stock will fund a new facility and early operations for support for Growery. This would help with a new “experiment” by the Dutch government. Here, they will be working with Growery to provide 80 coffee shops with marijuana to consume in a controlled environment over the next four years.

Such news is amazing for Aurora stock, as the company would have a foothold in a pioneering study. The Netherlands is set to be a leading consumer of cannabis, so having a strong presence here can only be good news for investors.

Now what?

So, is it too late to buy Aurora stock? Hardly. The company came down to below $1 per share on the NYSE, causing the company to perform a reverse stock split. So, if you want to see the numbers of 2018, you’ll need to wait quite some time. Whether Aurora stock can even get there is the question.

The main issue is that Aurora lacks a presence in the United States, despite having a presence in dozens of other countries. On top of that, it lacks a major partnership like the other big brands. While this leaves it room to do what it believes is best for the company, it also risks diluting shares, which it has … numerous times.

But there is hope for Aurora stock. Clearly, investors are still keen to watch the stock and will buy it back if there are signs of life. And this week, there were. The question now is whether Aurora stock can keep it up and continue to be the cheapest producer the cannabis world has to offer.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »